Clinical Trial

Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The study is to assess the safety of neffy or IM Adrenalin in patients who are experiencing allergic reactions after an OFC, allergen Immunotherapy (AIT), or other allergy challenge that may require epinephrine intervention.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-02-18; most recent amendment 2026-04-20.
Status change: Not Yet Recruiting → Recruiting 2025-10-24
Trial Details
NCT Number NCT06834165
Lead Sponsor ARS Pharmaceuticals, Inc.
Conditions Allergic Reactions
Enrollment 600 participants
Start Date 2025-05-20
Primary Completion 2027-04 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-21